国家中医药健康旅游建设经验交流暨标准研讨会在江西举行

2018-06-28 赵丹 中国中医

由国家中医药健康旅游示范建设工作办公室主办、江西省上饶市人民政府承办的国家中医药健康旅游建设经验交流暨标准研讨会在江西上饶市举行。国家中医药管理局国际合作司司长王笑频、江西省卫生和计划生育委员会副巡视员汪伟华、中共江西省上饶市市委书记马承祖出席了会议。中国中医科学院常务副院长、国家中医药健康旅游专家委员会主任委员黄璐琦主持了开幕式。

由国家中医药健康旅游示范建设工作办公室主办、江西省上饶市人民政府承办的国家中医药健康旅游建设经验交流暨标准研讨会在江西上饶市举行。国家中医药管理局国际合作司司长王笑频、江西省卫生和计划生育委员会副巡视员汪伟华、中共江西省上饶市市委书记马承祖出席了会议。中国中医科学院常务副院长、国家中医药健康旅游专家委员会主任委员黄璐琦主持了开幕式。

国家中医药健康旅游创建工作专家委员会部分专家、首批15家国家中医药健康旅游示范区创建单位及部分第一批国家中医药健康旅游示范基地创建单位的负责人及代表等参加了会议。会上,中国中医科学院常务副院长黄璐琦、北京工业大学教授王国华分别做了题为《国家中医药健康旅游示范创建工作进展及标准研制》及《中医药健康旅游产业跨界融合的理念与系统》主题报告。10家国家中医药健康旅游示范区及3家示范基地创建单位的代表在会上发言,并就中医药健康旅游示范区及示范基地的建设进展、特色资源、创建经验及未来规划等进行了交流和探讨。

2016年7月,原国家旅游局和国家中医药管理局启动国家中医药健康旅游示范区(基地、项目)创建工作,并于2017年9月和2018年3月分别公布了首批国家中医药健康旅游示范区及示范基地创建单位名单。此次会议的召开,加快了中医药健康旅游建设标准的研制工作。同时,通过各示范区和基地的经验交流、专家学者的现场点评,为示范区及基地的未来发展指明了方向,对推动中医药健康旅游产业的快速提升、实现中医药健康养生文化的创造性转化与创新性发展具有积极意义。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1805604, encodeId=432a180560416, content=<a href='/topic/show?id=91d5e8509e4' target=_blank style='color:#2F92EE;'>#经验交流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78509, encryptionId=91d5e8509e4, topicName=经验交流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3333505, createdName=gujh, createdTime=Sun Apr 21 22:03:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796831, encodeId=adfe1e96831ee, content=<a href='/topic/show?id=9a622150657' target=_blank style='color:#2F92EE;'>#中医药健康旅游#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21506, encryptionId=9a622150657, topicName=中医药健康旅游)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460849, createdName=ymljack, createdTime=Wed Aug 29 05:03:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994806, encodeId=bb0b1994806a7, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Oct 25 12:03:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409599, encodeId=198914095990b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Jun 30 11:03:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327734, encodeId=64df32e734ad, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jun 28 20:36:34 CST 2018, time=2018-06-28, status=1, ipAttribution=)]
    2019-04-21 gujh
  2. [GetPortalCommentsPageByObjectIdResponse(id=1805604, encodeId=432a180560416, content=<a href='/topic/show?id=91d5e8509e4' target=_blank style='color:#2F92EE;'>#经验交流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78509, encryptionId=91d5e8509e4, topicName=经验交流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3333505, createdName=gujh, createdTime=Sun Apr 21 22:03:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796831, encodeId=adfe1e96831ee, content=<a href='/topic/show?id=9a622150657' target=_blank style='color:#2F92EE;'>#中医药健康旅游#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21506, encryptionId=9a622150657, topicName=中医药健康旅游)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460849, createdName=ymljack, createdTime=Wed Aug 29 05:03:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994806, encodeId=bb0b1994806a7, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Oct 25 12:03:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409599, encodeId=198914095990b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Jun 30 11:03:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327734, encodeId=64df32e734ad, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jun 28 20:36:34 CST 2018, time=2018-06-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1805604, encodeId=432a180560416, content=<a href='/topic/show?id=91d5e8509e4' target=_blank style='color:#2F92EE;'>#经验交流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78509, encryptionId=91d5e8509e4, topicName=经验交流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3333505, createdName=gujh, createdTime=Sun Apr 21 22:03:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796831, encodeId=adfe1e96831ee, content=<a href='/topic/show?id=9a622150657' target=_blank style='color:#2F92EE;'>#中医药健康旅游#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21506, encryptionId=9a622150657, topicName=中医药健康旅游)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460849, createdName=ymljack, createdTime=Wed Aug 29 05:03:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994806, encodeId=bb0b1994806a7, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Oct 25 12:03:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409599, encodeId=198914095990b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Jun 30 11:03:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327734, encodeId=64df32e734ad, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jun 28 20:36:34 CST 2018, time=2018-06-28, status=1, ipAttribution=)]
    2018-10-25 kcb069
  4. [GetPortalCommentsPageByObjectIdResponse(id=1805604, encodeId=432a180560416, content=<a href='/topic/show?id=91d5e8509e4' target=_blank style='color:#2F92EE;'>#经验交流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78509, encryptionId=91d5e8509e4, topicName=经验交流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3333505, createdName=gujh, createdTime=Sun Apr 21 22:03:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796831, encodeId=adfe1e96831ee, content=<a href='/topic/show?id=9a622150657' target=_blank style='color:#2F92EE;'>#中医药健康旅游#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21506, encryptionId=9a622150657, topicName=中医药健康旅游)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460849, createdName=ymljack, createdTime=Wed Aug 29 05:03:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994806, encodeId=bb0b1994806a7, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Oct 25 12:03:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409599, encodeId=198914095990b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Jun 30 11:03:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327734, encodeId=64df32e734ad, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jun 28 20:36:34 CST 2018, time=2018-06-28, status=1, ipAttribution=)]
    2018-06-30 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1805604, encodeId=432a180560416, content=<a href='/topic/show?id=91d5e8509e4' target=_blank style='color:#2F92EE;'>#经验交流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78509, encryptionId=91d5e8509e4, topicName=经验交流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3333505, createdName=gujh, createdTime=Sun Apr 21 22:03:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796831, encodeId=adfe1e96831ee, content=<a href='/topic/show?id=9a622150657' target=_blank style='color:#2F92EE;'>#中医药健康旅游#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21506, encryptionId=9a622150657, topicName=中医药健康旅游)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=460849, createdName=ymljack, createdTime=Wed Aug 29 05:03:00 CST 2018, time=2018-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994806, encodeId=bb0b1994806a7, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Thu Oct 25 12:03:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409599, encodeId=198914095990b, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Jun 30 11:03:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327734, encodeId=64df32e734ad, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jun 28 20:36:34 CST 2018, time=2018-06-28, status=1, ipAttribution=)]
    2018-06-28 医者仁心5538

    学习了

    0

相关资讯

国家中医药局召开局务(扩大)会议,积极谋划确保全年工作良好开局

1月26日,国家中医药管理局召开2017年第四次局务(扩大)会议,总结2017年工作情况,部署下阶段重点任务。国家卫生计生委副主任、国家中医药管理局局长王国强主持会议并强调,要深入学习领会十九大精神,抓好统筹谋划,推动全年工作实现良好开局。

Heart:酒精性心肌病所致的国家、区域和全球死亡率!

由此可见,ACM死亡负担的变异性要大于其他酒精引起的疾病,部分原因可能是由于疾病特征和检测手段不足。错误的ACM分类是一个系统的现象,这可能是由于资源较少、缺乏标准和与酒精使用疾病相关的特征。通过常规的酒精评估,可以改善临床管理。这可能有助于减少错误分类,并为患者提供最好的治疗。

这些中医药获国家科技大奖!

所谓匠心,一生只做一件事,做好这件事;所谓传承,继承先辈之精华,并钻研之。正如今年在全国两会的部长通道上,原国家中医药管理局局长王国强所说,真正让中国中医药走向世界,能够更好造福人类健康,中国首先要做好自己的事情。无论是在疑难病,还是常见病、慢性病的诊治上,中国中医药都在继承中发展。日前,健康时报记者采访了自2010年至2017年八年间国家科学技术进步奖中医药项目的部分专家团队,详细了解这些

国家将重点支持24个医疗健康项目

近日,国家知识产权局印发《知识产权重点支持产业目录(2018年本)》,明确了国家重点发展和亟需知识产权支持的十大重点产业,包括现代农业产业、新一代信息技术产业、智能制造产业、先进生物产业、健康产业等。据了解,该《目录》中的产业主要是根据《国家创新驱动发展战略纲要》《国家信息化发展战略纲要》《“十三五”国家科技创新发展规划》《中国制造2025》《“十三五”国家战略性新兴产业发展规划》《“十三五”旅游

2018国家自然科学技术奖受理项目(生物和基础医学组)

2018国家自然科学技术奖受理项目(生物和基础医学组)

国家卫生健康委员会召开会议

3月22日,国家卫生健康委员会召开领导干部会议。全国政协副主席李斌主持会议并讲话。中央组织部分管日常工作的副部长(正部长级)姜信治宣布了中央关于组建国家卫生健康委员会和领导班子任职的决定,对党的十八大以来卫生健康事业改革发展取得的成绩给予充分肯定,对原国家卫生计生委党组和系统干部职工工作给予充分肯定,并就全面、系统、准确学习领会习近平总书记关于卫生健康工作重要指示精神,推动落实好健康中国战略提出了